Arkuda Therapeutics

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Bristol, VantAI Pair Technologies In Pr

Twelve biopharmaceutical companies announced venture capital financings totaling $672m between 7 and 11 February, which was another relatively quiet week for public company offerings. With biotechnolo

AN2 Launches With $12m In Series A Funding AN2 Therapeutics Inc. launched with $12m in series A financing led by Mountain Group Partners, which was joined by Adjuvant Capital, partner Brii Bioscien